Prophylactic prednisolone for the prevention of early and intermediate adverse effects of radioactive iodine therapy in patients with thyroid cancer: study protocol for a single-centre, phase II/III, randomized, double-blinded, placebo-controlled clinical trial.
Umesh JayarajahMahilal WijekoonSanjeewa A SeneviratnePublished in: Trials (2020)
Sri Lanka Clinical Trials Registry SLCTR/2020/009 . Registered prospectively on 23 February 2020. Items of the WHO Trial Registration Data Set are provided in the supplementary file.
Keyphrases
- phase ii
- clinical trial
- placebo controlled
- double blind
- phase iii
- open label
- study protocol
- electronic health record
- phase ii study
- big data
- magnetic resonance imaging
- randomized controlled trial
- squamous cell carcinoma
- machine learning
- magnetic resonance
- stem cells
- emergency department
- deep learning
- replacement therapy
- radiation therapy